Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
miRNA Delivery: Emerging Therapy for Hepatocellular Carcinoma — Sara Toffanin (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
miRNA Delivery: Emerging Therapy for Hepatocellular Carcinoma
Shared by
Josep M. Llovet
miRNA Delivery: Emerging Therapy for Hepatocellular Carcinoma
Letter
2010
English
Authors
ST
Sara Toffanin
AV
Augusto Villanueva
Josep M. Llovet
Translational Research In Hepatic Oncology
Abstract
1 min read
No abstract is provided for this article.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
Emerging agents for the medical therapy of hepatocellular carcinoma.
Josep M. Llovet
PubMed
Article
2023
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
Amit G. Singal
,
Fasiha Kanwal
,
Josep M. Llovet
Nature Reviews Clinical Oncology
Article
2006
New aspects of diagnosis and therapy of hepatocellular carcinoma
Jordi Bruix
,
Amelia J. Hessheimer
,
Alejandro Forner
,
Loreto Boix
,
R. Vilana
,
Josep M. Llovet
Oncogene
Chapter in a book
2008
Algorithms of diagnosis and options of hepatocellular carcinoma therapy
Alejandro Forner
,
Josep M. Llovet
Article
2021
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet
,
Florian Castet
,
Mathias Heikenwälder
,
Mala K. Maini
,
Vincenzo Mazzaferro
,
David J. Pinato
,
Eli Pikarsky
,
Andrew X. Zhu
,
Richard S. Finn
Nature Reviews Clinical Oncology
Discussion(0)
No comments yet. Be the first to comment.